Does ELOTUZUMAB Cause C-reactive protein increased? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of C-reactive protein increased have been filed in association with ELOTUZUMAB (EMPLICITI). This represents 0.5% of all adverse event reports for ELOTUZUMAB.
17
Reports of C-reactive protein increased with ELOTUZUMAB
0.5%
of all ELOTUZUMAB reports
1
Deaths
16
Hospitalizations
How Dangerous Is C-reactive protein increased From ELOTUZUMAB?
Of the 17 reports, 1 (5.9%) resulted in death, 16 (94.1%) required hospitalization, and 1 (5.9%) were considered life-threatening.
Is C-reactive protein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELOTUZUMAB. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does ELOTUZUMAB Cause?
Plasma cell myeloma (339)
Death (234)
Malignant neoplasm progression (227)
Pneumonia (209)
Pyrexia (183)
Drug ineffective (137)
Neutropenia (133)
Anaemia (119)
Thrombocytopenia (107)
Diarrhoea (105)
What Other Drugs Cause C-reactive protein increased?
METHOTREXATE (5,999)
ADALIMUMAB (4,579)
RITUXIMAB (4,060)
ETANERCEPT (3,922)
TOCILIZUMAB (3,719)
INFLIXIMAB (3,621)
LEFLUNOMIDE (3,574)
HYDROXYCHLOROQUINE (3,552)
ABATACEPT (3,451)
SULFASALAZINE (3,096)
Which ELOTUZUMAB Alternatives Have Lower C-reactive protein increased Risk?
ELOTUZUMAB vs ELOXATIN
ELOTUZUMAB vs ELRANATAMAB
ELOTUZUMAB vs ELRANATAMAB-BCMM
ELOTUZUMAB vs ELTROMBOPAG
ELOTUZUMAB vs ELTROMBOPAG OLAMINE